Patient Story: CaRi-Heart Analysis gave Christian certainty and assurance about his heart health

Christian, a patient from Nuremberg, Germany had a family history of Coronary Artery Disease.

He was worried that he would have the same fate as his father,

“As a young child I had a traumatic experience when my father died of a heart attack when he was only 38. I still have memories of this tragic event… As I approached the age of 38, I was getting increasingly afraid that I could die any day, life my father, and could not have a normal life.”

Christian, consulted with Dr Martin Laser who recommended a cardiac CT scan with the CaRi-Heart Analysis to better understand and diagnose his coronary artery disease. Watch this video featuring Christian, to learn how the CaRi-Heart Analysis helped him understand his condition better and gave him assurance about his heart health

CaRi-Heart technology is Caristo’s flagship offering which aids coronary artery disease diagnosis with improved risk prediction. It applies advanced AI algorithms to routine cardiac CT scans to visualize and quantify coronary inflammation, which is the previously invisible root cause of the disease. Each patient’s CaRi-Heart Report includes several clinical results:

• the patient specific Fat Attenuation Index (FAI), a novel and patented biomarker for the measurement of coronary inflammation, which indicates the patient’s risk in % relative to a matched peer group;
• CaRi-Heart Risk, which assesses the absolute 8-year risk of a fatal heart attack (based on both coronary inflammation status and standard clinical risks factors); and
• coronary plaque-specific characterization and quantification.

The CaRi-Heart Analysis is supported by the CaRi-Heart software, which is cloud-based and agnostic to the type of scanner generating the routine cardiac CT images. The CaRi-Heart technology is CE Mark certified under the latest EU MDR with UKCA marking being received in September 2022.